BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2945294)

  • 1. Lipoprotein(a) as a strong indicator for cerebrovascular disease.
    Zenker G; Költringer P; Boné G; Niederkorn K; Pfeiffer K; Jürgens G
    Stroke; 1986; 17(5):942-5. PubMed ID: 2945294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Lipoprotein(a) Level with Cerebral Small Vessel Disease in Patients with Alzheimer's Disease.
    Chen N; Jiang F; Chen X; Zhu L; Qiao N; Zhou J; Zhang Y
    Brain Sci; 2023 Dec; 14(1):. PubMed ID: 38248249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein(a) as a Risk Factor for Cardiovascular Diseases: Pathophysiology and Treatment Perspectives.
    Vinci P; Di Girolamo FG; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Altamura N; Pirulli A; Zaccari M; Biasinutto C; Roni C; Fiotti N; Schincariol P; Mangogna A; Biolo G
    Int J Environ Res Public Health; 2023 Sep; 20(18):. PubMed ID: 37754581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein (a) level as a risk factor for stroke and its subtype: A systematic review and meta-analysis.
    Kumar P; Swarnkar P; Misra S; Nath M
    Sci Rep; 2021 Aug; 11(1):15660. PubMed ID: 34341405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?
    Enkhmaa B; Petersen KS; Kris-Etherton PM; Berglund L
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32646066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology.
    Nordestgaard BG; Langsted A
    J Lipid Res; 2016 Nov; 57(11):1953-1975. PubMed ID: 27677946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.
    Leung YY; Toledo JB; Nefedov A; Polikar R; Raghavan N; Xie SX; Farnum M; Schultz T; Baek Y; Deerlin VV; Hu WT; Holtzman DM; Fagan AM; Perrin RJ; Grossman M; Soares HD; Kling MA; Mailman M; Arnold SE; Narayan VA; Lee VM; Shaw LM; Baker D; Wittenberg GM; Trojanowski JQ; Wang LS
    Alzheimers Dement (Amst); 2015 Sep; 1(3):339-348. PubMed ID: 26693175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoascorbemia induces atherosclerosis and vascular deposition of lipoprotein(a) in transgenic mice.
    Cha J; Niedzwiecki A; Rath M
    Am J Cardiovasc Dis; 2015; 5(1):53-62. PubMed ID: 26064792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caloric restriction: powerful protection for the aging heart and vasculature.
    Weiss EP; Fontana L
    Am J Physiol Heart Circ Physiol; 2011 Oct; 301(4):H1205-19. PubMed ID: 21841020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enigmatic role of lipoprotein(a) in cardiovascular disease.
    Anuurad E; Enkhmaa B; Berglund L
    Clin Transl Sci; 2010 Dec; 3(6):327-32. PubMed ID: 21167011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a), homocysteine, and retinal arteriosclerosis.
    Ghorbanihaghjo A; Javadzadeh A; Argani H; Nezami N; Rashtchizadeh N; Rafeey M; Rohbaninoubar M; Rahimi-Ardabili B
    Mol Vis; 2008 Sep; 14():1692-7. PubMed ID: 18806883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): an elusive cardiovascular risk factor.
    Berglund L; Ramakrishnan R
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2219-26. PubMed ID: 15345512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones and heart disease: what we thought, what we have learned, what we still need to know.
    Limacher MC
    Trans Am Clin Climatol Assoc; 2002; 113():31-40; discussion 40-1. PubMed ID: 12053716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease.
    Solfrizzi V; Panza F; D'Introno A; Colacicco AM; Capurso C; Basile AM; Capurso A
    J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):732-6. PubMed ID: 12023414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population.
    Paultre F; Tuck CH; Boden-Albala B; Kargman DE; Todd E; Jones J; Paik MC; Sacco RL; Berglund L
    Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):141-6. PubMed ID: 11788474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.
    Sarti C; Kaarisalo M; Tuomilehto J
    Drugs Aging; 2000 Jul; 17(1):33-51. PubMed ID: 10933514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipids in young patients with ischaemic stroke: a case-control study.
    Albucher JF; Ferrieres J; Ruidavets JB; Guiraud-Chaumeil B; Perret BP; Chollet F
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):29-33. PubMed ID: 10864600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.
    Chu NF; Makowski L; Chang JB; Wang DJ; Liou SH; Shieh SM
    Eur J Epidemiol; 2000 Jan; 16(1):5-12. PubMed ID: 10780336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An application of apo(a) isoforms for the clinical assessment of Lp(a).
    Takayama S; Yasumuro Y; Kim Jh; Ishikawa M; Tsujino D; Matsuo S; Harada Y; Sugii S
    J Clin Lab Anal; 2000; 14(2):53-8. PubMed ID: 10683614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of exercise on lipoprotein(a).
    Mackinnon LT; Hubinger LM
    Sports Med; 1999 Jul; 28(1):11-24. PubMed ID: 10461709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.